Recent Finacing
Recent Raise
Coferon develops reversible covalent bioorthogonal linker chemistries that enable intracellular self-assembly of small-molecule dimers to enhance potency and selectivity, applied to anti-infectives and BRD-family epigenetic targets.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors